The lysosome: From waste bag to potential therapeutic target

Journal of Molecular Cell Biology

Volumn 5, Issue 4, 2013, Pages 214-226

  Appelqvist, Hanna ^a   Wäster, Petra ^a   Kågedal, Katarina ^a   Öllinger, Karin ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Clinical Immunology and Transfusion Medicine   (Sweden)

Author keywords

apoptosis; cholesterol; degradation; exocytosis; lysosomal membrane permeabilization

Indexed keywords

CATHEPSIN; CHOLESTEROL; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; TRANSCRIPTION FACTOR;

AUTOPHAGY; BIOGENESIS; CELL DEATH; CELL FUNCTION; CELL MEMBRANE; CELL ORGANELLE; DIGESTION; ENDOCYTOSIS; HOMEOSTASIS; INTRACELLULAR SIGNALING; LYSOSOME; MACROMOLECULE; PHAGOCYTOSIS; REGULATORY MECHANISM; REVIEW;

EID: 84881565288     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjt022     Document Type: Review

References (196)

1. Abok, K.,Hirth, T.,Ericsson, J.L., et al. (1983). Effect of irononthe stabilityofmacrophage lysosomes. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 43, 85-101.
2. Andrews, N.W. (2000). Regulated secretion of conventional lysosomes. Trends Cell Biol. 10, 316-321. (Pubitemid 30445238)
3. Andrews, N.W. (2005).Membrane repair and immunological danger. EMBO Rep. 6, 826-830. (Pubitemid 43108671)
4. Andrews, N.W., and Chakrabarti, S. (2005). There's more to life than neurotransmission: the regulation of exocytosis by synaptotagmin VII. Trends Cell Biol. 15, 626-631. (Pubitemid 41619427)
5. Appelmans, F., Wattiaux, R., and De Duve, C. (1955). Tissue fractionation studies. 5.
6. The association of acid phosphatase with a special class of cytoplasmic granules in rat liver. Biochem. J. 59, 438-445.
7. Appelqvist, H., Nilsson, C., Garner, B., et al. (2011). Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation. Am. J. Pathol. 178, 629-639.
8. Appelqvist, H., Johansson, A.C., Linderoth, E., et al. (2012a). Lysosome-mediated apoptosis is associated with cathepsin D-specific processing of Bid at Phe24, Trp48, and Phe183. Ann. Clin. Lab. Sci. 42, 231-242.
9. Appelqvist, H., Sandin, L., Bjo?rnstro?m, K., et al. (2012b). Sensitivity to lysosomedependent cell death is directly regulated by lysosomal cholesterol content. PLoS One 7, e50262.
10. Bach, G., Chen, C.S., and Pagano, R.E. (1999). Elevated lysosomal pH in Mucolipidosis type IV cells. Clin. Chim. Acta 280, 173-179. (Pubitemid 29094592)
11. Bahr, B.A., Wisniewski, M.L., and Butler, D. (2012). Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases. Rejuvenation Res. 15, 189-197.
12. Bainton, D.F. (1981). The discovery of lysosomes. J. Cell Biol. 91, 66s-76s. (Pubitemid 12177861)
13. Ballabio, A., and Gieselmann, V. (2009). Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta 1793, 684-696.
14. Bellettato, C.M., and Scarpa, M. (2010). Pathophysiology of neuropathic lysosomal storage disorders. J. Inherit. Metab. Dis. 33, 347-362.
15. Bendiske, J., and Bahr, B.A. (2003). Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis - an approach for slowing Alzheimer disease? J. Neuropathol. Exp. Neurol. 62, 451-463. (Pubitemid 36560187)
16. Bengtsson, E., To, F., Grubb, A., et al. (2005). Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. Atherosclerosis 180, 45-53.
17. Bide're, N., Lorenzo, H.K., Carmona, S., et al. (2003). Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278, 31401-31411. (Pubitemid 36994661)
18. Bivik, C., Larsson, P., Kagedal, K., et al. (2006). UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members. J. Invest. Dermatol. 126, 1119-1127.
19. Bivik, C., Rosdahl, I., and O?llinger, K. (2007). Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes. Carcinogenesis 28, 537-544. (Pubitemid 46523349)
20. Blomgran, R., Zheng, L., and Stendahl, O. (2007). Cathepsin-cleaved Bid promotes apoptosis inhuman neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J. Leukoc. Biol. 81, 1213-1223. (Pubitemid 46702040)
21. Boya, P., Andreau, K., Poncet, D., et al. (2003). Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 197, 1323-1334. (Pubitemid 36617779)
22. Broker, L.E., Huisman, C., Span, S.W., et al. (2004). Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res. 64, 27-30. (Pubitemid 38114077)
23. Brown, M.S., and Goldstein, J.L. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47. (Pubitemid 16037973)
24. Brown, W.J., Goodhouse, J., and Farquhar, M.G. (1986). Mannose-6-phosphate receptors for lysosomal enzymes cycle between the Golgi complex and endosomes. J. Cell Biol. 103, 1235-1247. (Pubitemid 17174150)
25. Brunk, U.T., and Svensson, I. (1999). Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep. 4, 3-11. (Pubitemid 29296774)
26. Brzin, J., Kopitar, M., Turk, V., et al. (1983). Protein inhibitors of cysteine proteinases. I. Isolation and characterization of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe Seylers Z. Physiol. Chem. 364, 1475-1480. (Pubitemid 14176947)
27. Bucci, C., Thomsen, P., Nicoziani, P., et al. (2000). Rab7: a key to lysosome biogenesis. Mol. Biol. Cell 11, 467-480. (Pubitemid 30112158)
28. Burman, C., and Ktistakis, N.T. (2010). Autophagosome formation in mammalian cells. Semin. Immunopathol. 32, 397-413.
29. Bursch, W., Ellinger, A., Gerner, C., et al. (2000). Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann. NY Acad. Sci. 926, 1-12. (Pubitemid 32050138)
30. Butler, D., Hwang, J., Estick, C., et al. (2011). Protective effects of positive lysosomal modulation in Alzheimer's disease transgenicmousemodels. PLoSOne 6, e20501.
31. Bygrave, F.L., and Benedetti, A. (1996). What is the concentration of calcium ions in the endoplasmic reticulum? Cell Calcium 19, 547-551. (Pubitemid 26248770)
32. Caccamo, A., Majumder, S., Richardson, A., et al. (2010). Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107-13120.
33. Carstea, E.D., Morris, J.A., Coleman, K.G., et al. (1997). Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277, 228-231. (Pubitemid 27446076)
34. Caruso, J.A., Mathieu, P.A., and Reiners, J.J., Jr (2005). Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy. Biochem. J. 392, 325-334. (Pubitemid 41796521)
35. Caruso, J.A., Mathieu, P.A., Joiakim, A., et al. (2006). Aryl hydrocarbon receptor modulation of tumor necrosis factor-alpha-induced apoptosis and lysosomal disruption in a hepatoma model that is caspase-8-independent. J. Biol. Chem. 281, 10954-10967. (Pubitemid 43855518)
36. Chen, F.W., Li, C., and Ioannou, Y.A. (2010). Cyclodextrin induces calciumdependent lysosomal exocytosis. PLoS One 5, e15054.
37. Cheng, X.W., Kuzuya, M., Nakamura, K., et al. (2006). Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am. J. Pathol. 168, 685-694. (Pubitemid 43271165)
38. Cheng, X.W., Huang, Z., Kuzuya, M., et al. (2011). Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension 58, 978-986.
39. Cheung, Z.H., and Ip, N.Y. (2011). Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives. J. Neurochem. 118, 317-325.
40. Christensen, K.A., Myers, J.T., and Swanson, J.A. (2002). pH-dependent regulation of lysosomal calcium in macrophages. J. Cell Sci. 115, 599-607. (Pubitemid 34182986)
41. Churchill, G.C., Okada, Y., Thomas, J.M., et al. (2002). NAADP mobilizes Ca2+ from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 111, 703-708. (Pubitemid 35441251)
42. Cirman, T., Oresic, K., Mazovec, G.D., et al. (2004). Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J. Biol. Chem. 279, 3578-3587. (Pubitemid 38140598)
43. Coen, K., Flannagan, R.S., Baron, S., et al. (2012). Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 198, 23-35.
44. Coffey, J.W., and De Duve, C. (1968). Digestive activity of lysosomes. I. The digestion of proteins by extracts of rat liver lysosomes. J. Biol. Chem. 243, 3255-3263.
45. Conus, S., Perozzo, R., Reinheckel, T., et al. (2008). Caspase-8 is activated by cathepsin Dinitiating neutrophil apoptosis during the resolution of inflammation. J. Exp. Med. 205, 685-698. (Pubitemid 351439313)
46. Corre, I., Niaudet, C., and Paris, F. (2010). Plasma membrane signaling induced by ionizing radiation. Mutat. Res. 704, 61-67.
47. Cuervo, A.M., and Dice, J.F. (1996). A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273, 501-503. (Pubitemid 26286451)
48. de Duve, C. (1959). Lysosomes, a new group of cytoplasmic particles. In: Hayashi, T. (ed). Subcellular Particles. New York: The Ronald Press Co., 128-159.
49. Deleze, J. (1970). The recovery of resting potential and input resistance in sheep heart injured by knife or laser. J. Physiol. 208, 547-562.
50. Dice, J.F. (1990). Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem. Sci. 15, 305-309. (Pubitemid 20223216)
51. Doyotte, A., Russell, M.R., Hopkins, C.R., et al. (2005). Depletion of TSG101 forms a mammalian 'Class E' compartment: a multicisternal early endosome with multiple sorting defects. J. Cell Sci. 118, 3003-3017. (Pubitemid 41149905)
52. Droga-Mazovec, G., Bojic, L., Petelin, A., et al. (2008). Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 283, 19140-19150.
53. Duewell, P., Kono, H., Rayner, K.J., et al. (2010). NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361.
54. Efeyan, A., Zoncu, R., and Sabatini, D.M. (2012). Amino acids and mTORC1: from lysosomes to disease. Trends Mol. Med. 18, 524-533.
55. Elrick, M.J., Yu, T., Chung, C., et al. (2012). Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease. Hum. Mol. Genet. 21, 4876-4887.
56. Erdal, H., Berndtsson, M., Castro, J., et al. (2005). Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc. Natl Acad. Sci. USA 102, 192-197. (Pubitemid 40094451)
57. Eriksson, I., Joosten, M., Roberg, K., et al. (2013). The histone deacetylase inhibitor trichostatin Areduces lysosomalpHand enhances cisplatin-induced apoptosis. Exp. Cell Res. 319, 12-20.
58. Eskelinen, E.L., Tanaka, Y., and Saftig, P. (2003). At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13, 137-145. (Pubitemid 36293786)
59. Fehrenbacher, N., Gyrd-Hansen, M., Poulsen, B., et al. (2004). Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res. 64, 5301-5310. (Pubitemid 39006550)
60. Fehrenbacher, N., Bastholm, L., Kirkegaard-Sorensen, T., et al. (2008). Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res. 68, 6623-6633.
61. Foghsgaard, L., Wissing, D., Mauch, D., et al. (2001). Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999-1010.
62. Gocheva, V., Zeng, W., Ke, D., et al. (2006). Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556. (Pubitemid 43345321)
63. Gonzalez, M.R., Bischofberger, M., Pernot, L., et al. (2008). Bacterial poreforming toxins: the (w)hole story? Cell. Mol. Life Sci. 65, 493-507.
64. Gottlieb, R.A., Giesing, H.A., Zhu, J.Y., et al. (1995). Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H+-ATPase. Proc. Natl Acad. Sci. USA 92, 5965-5968.
65. Granger, B.L., Green, S.A., Gabel, C.A., et al. (1990). Characterization and cloning of lgp110, a lysosomal membrane glycoprotein from mouse and rat cells. J. Biol. Chem. 265, 12036-12043.
66. Groth-Pedersen, L., and Ja?a?ttela?.M. (2013). Combating apoptosis and multidrug resistant cancers by targeting lysosomes. Cancer Lett. 332, 265-274.
67. Guicciardi, M.E., Deussing, J., Miyoshi, H., et al. (2000). Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106, 1127-1137.
68. Hara, T., Nakamura, K., Matsui, M., et al. (2006). Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889.
69. Harris, H., and Rubinsztein, D.C. (2011). Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108-117.
70. Heinrich, M., Neumeyer, J., Jakob, M., et al. (2004). Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 11, 550-563. (Pubitemid 38660140)
71. Holopainen, J.M., Angelova, M.I., and Kinnunen, P.K. (2000). Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys. J. 78, 830-838. (Pubitemid 30211840)
72. Houseweart, M.K., Vilaythong, A., Yin, X.M., et al. (2003). Apoptosis caused by cathepsins does not require Bid signaling in an in vivo model of progressive myoclonus epilepsy (EPM1). Cell Death Differ. 10, 1329-1335. (Pubitemid 37536737)
73. Huizing, M., Helip-Wooley, A., Westbroek, W., et al. (2008). Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu. Rev. Genomics Hum. Genet. 9, 359-386.
74. Huotari, J., and Helenius, A. (2011). Endosome maturation. EMBO J. 30, 3481-3500.
75. Idone, V., Tam, C., Goss, J.W., et al. (2008). Repair of injured plasma membrane by rapid Ca2+-dependent endocytosis. J. Cell Biol. 180, 905-914. (Pubitemid 351398418)
76. Ishisaka, R., Utsumi, T., Yabuki, M., et al. (1998). Activation of caspase-3-like protease by digitonin-treated lysosomes. FEBS Lett. 435, 233-236. (Pubitemid 28435007)
77. Ivanova, S., Gregorc, U., Vidergar, N., et al. (2011).MAGUKs, scaffolding proteins at cell junctions, are substrates of different proteases during apoptosis. Cell Death Dis. 2, e116.
78. Ja?a?ttela?, M., Benedict, M., Tewari, M., et al. (1995). Bcl-x and Bcl-2 inhibit TNFand Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10, 2297-2305.
79. Jaiswal, J.K., Andrews, N.W., and Simon, S.M. (2002). Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J. Cell Biol. 159, 625-635.
80. Johansson, A.C., Appelqvist, H., Nilsson, C., et al. (2010). Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 15, 527-540.
81. Jormsjo?, S., Wuttge, D.M., Sirsjo?, A., et al. (2002). Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 161, 939-945. (Pubitemid 34988381)
82. Kagedal, K., Zhao, M., Svensson, I., et al. (2001). Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359, 335-343. (Pubitemid 32999777)
83. Kagedal, K., Johansson, A.C., Johansson, U., et al. (2005). Lysosomal membrane permeabilization during apoptosis - involvement of Bax? Int. J. Exp. Pathol. 86, 309-321. (Pubitemid 41413626)
84. Kallunki, T., Olsen, O.D., and Jaattela, M (2013). Cancer-associated Lysosomal Changes: Friends or Foes? Oncogene 32, 1995-2004.
85. Katunuma, N., Matsui, A., Le, Q.T., et al. (2001). Novel procaspase-3 activating cascade mediated by lysoapoptases and its biological significances in apoptosis. Adv. Enzyme Regul. 41, 237-250.
86. Kaushik, S., and Cuervo, A.M. (2012). Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 22, 407-417.
87. Kirkegaard, T., and Ja?a?ttela?, M. (2009). Lysosomal involvement in cell death and cancer. Biochim. Biophys. Acta 1793, 746-754.
88. Kirkegaard, T., Roth, A.G., Petersen, N.H., et al. (2010). Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 463, 549-553.
89. Kirschke, H., Wiederanders, B., Bromme, D., et al. (1989). Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem. J. 264, 467-473. (Pubitemid 20024516)
90. Kobayashi, T., Stang, E., Fang, K.S., et al. (1998). A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 392, 193-197. (Pubitemid 28162794)
91. Komatsu, M., Waguri, S., Chiba, T., et al. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884.
92. Korolchuk, V.I., Saiki, S., Lichtenberg, M., et al. (2011). Lysosomal positioning coordinates cellular nutrient responses. Nat. Cell Biol. 13, 453-460.
93. Kreuzaler, P.A., Staniszewska, A.D., Li, W., et al. (2011). Stat3 controls lysosomal-mediated cell death in vivo. Nat. Cell Biol. 13, 303-309.
94. Kwon, H.J., Abi-Mosleh, L., Wang, M.L., et al. (2009). Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137, 1213-1224.
95. Lange, Y., Swaisgood, M.H., Ramos, B.V., et al. (1989). Plasma membranes contain half the phospholipid and 90%of the cholesterol and sphingomyelin in cultured human fibroblasts. J. Biol. Chem. 264, 3786-3793.
96. Laurent-Matha, V., Huesgen, P.F., Masson, O., et al. (2012). Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J. 26, 5172-5181.
97. Lee, A.Y., Gulnik, S.V., and Erickson, J.W. (1998). Conformational switching in an aspartic proteinase. Nat. Struct. Biol. 5, 866-871. (Pubitemid 28467407)
98. Lee, J.H., Yu,W.H., Kumar, A., et al. (2010). Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146-1158.
99. Lee, J., Giordano, S., and Zhang, J. (2012). Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441, 523-540.
100. Levine, B., and Kroemer, G. (2008). Autophagy in the pathogenesis of disease. Cell 132, 27-42.
101. Li, W., and Yuan, X.M. (2004). Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis. Ann. NY Acad. Sci. 1030, 427-433. (Pubitemid 40378942)
102. Li, W., Yuan, X.M., Olsson, A.G., et al. (1998). Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler. Thromb. Vasc. Biol. 18, 177-184. (Pubitemid 28277593)
103. Li, N., Zheng, Y., Chen,W., et al. (2007). Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis. Cancer Res. 67, 11176-11185. (Pubitemid 350248542)
104. Li,W., Kornmark, L., Jonasson, L., et al. (2009). Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 202, 92-102.
105. Li, W.W., Li, J., and Bao, J.K. (2012). Microautophagy: lesser-known self-eating. Cell. Mol. Life Sci. 69, 1125-1136.
106. Liu, J., Sukhova, G.K., Yang, J.T., et al. (2006a). Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 184, 302-311. (Pubitemid 43049714)
107. Liu, J., Ma, L., Yang, J., et al. (2006b). Increased serum cathepsinSin patients with atherosclerosis and diabetes. Atherosclerosis 186, 411-419.
108. Liu, Y., Zhou, Y., and Zhu, K. (2012). Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS One 7, e45910.
109. Lloyd, J.B. (1996). Metabolite efflux and influx across the lysosome membrane. Subcell. Biochem. 27, 361-386.
110. Lloyd-Evans, E., and Platt, F.M. (2011). Lysosomal Ca2+ homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 50, 200-205.
111. Lloyd-Evans, E., Morgan, A.J., He, X., et al. (2008). Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14, 1247-1255.
112. Lu?bke, T., Lobel, P., and Sleat, D.E. (2009). Proteomics of the lysosome. Biochim. Biophys. Acta 1793, 625-635.
113. Lu?llmann-Rauch, R. (2005). History and morphology of the lysosome. In: Saftig, P. (ed). Lysosomes. New York: Springer
114. Lutgens, E., Lutgens, S.P., Faber, B.C., et al. (2006). Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113, 98-107. (Pubitemid 43958494)
115. Lutgens, S.P., Cleutjens, K.B., Daemen, M.J., et al. (2007). Cathepsin cysteine proteases in cardiovascular disease. FASEB J. 21, 3029-3041. (Pubitemid 47565524)
116. Marshansky, V., and Futai, M. (2008). The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 20, 415-426.
117. Martinez, I., Chakrabarti, S., Hellevik, T., et al. (2000). Synaptotagmin VII regulates Ca2+-dependent exocytosis of lysosomes in fibroblasts. J. Cell Biol. 148, 1141-1149.
118. Matsuyama, S., Llopis, J., Deveraux, Q.L., et al. (2000). Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat. Cell Biol. 2, 318-325.
119. Maxfield, F.R., and Wustner, D. (2002). Intracellular cholesterol transport. J. Clin. Invest. 110, 891-898.
120. McNeil, P.L. (2002). Repairing a torn cell surface: make way, lysosomes to the rescue. J. Cell Sci. 115, 873-879. (Pubitemid 34257372)
121. McNeil, P.L., and Khakee, R. (1992). Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am. J. Pathol. 140, 1097-1109.
122. Medina, D.L., Fraldi, A., Bouche, V., et al. (2011). Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell 21, 421-430.
123. Michel, V., Licon-Munoz, Y., Trujillo, K., et al. (2013). Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion. Int. J. Cancer 132, E1-E10.
124. Mindell, J.A. (2012). Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74, 69-86.
125. Mirnikjoo, B., Balasubramanian, K., and Schroit, A.J. (2009). Mobilization of lysosomal calcium regulates the externalization of phosphatidylserine during apoptosis. J. Biol. Chem. 284, 6918-6923.
126. Mizushima, N., and Komatsu, M. (2011). Autophagy: renovation of cells and tissues. Cell 147, 728-741.
127. Mo?bius, W., van Donselaar, E., Ohno-Iwashita, Y., et al. (2003). Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic 4, 222-231. (Pubitemid 36665383)
128. Morgan, A.J., Platt, F.M., Lloyd-Evans, E., et al. (2011). Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease. Biochem. J. 439, 349-374.
129. Mu, F.T., Callaghan, J.M., Steele-Mortimer, O., et al. (1995). EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine 'fingers' and contains a calmodulinbinding IQ motif. J. Biol. Chem. 270, 13503-13511.
130. Neufeld, E.B., Wastney, M., Patel, S., et al. (1999). The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J. Biol. Chem. 274, 9627-9635.
131. Nilsson, C., Johansson, U., Johansson, A.C., et al. (2006). Cytosolic acidification and lysosomal alkalinization during TNF-alpha induced apoptosis in U937 cells. Apoptosis 11, 1149-1159. (Pubitemid 44035964)
132. Nilsson, C., Roberg, K., Grafstro?m, R.C., et al. (2010). Intrinsic differences in cisplatin sensitivity of head and neck cancer cell lines: Correlation to lysosomal pH. Head Neck 32, 1185-1194.
133. Nixon, R.A., and Yang, D.S. (2011). Autophagy failure in Alzheimer's disease - locating the primary defect. Neurobiol. Dis. 43, 38-45.
134. Nixon, R.A., Yang, D.S., and Lee, J.H. (2008). Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4, 590-599.
135. Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., et al. (2004). Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 200, 425-435. (Pubitemid 39121900)
136. Ohkuma, S., and Poole, B. (1978). Fluorescence probe measurement of the intralysosomalpHin living cells and the perturbation ofpHby various agents. Proc. Natl Acad. Sci. USA 75, 3327-3331. (Pubitemid 8389720)
137. Ohkuma, S., Moriyama, Y., and Takano, T. (1982). Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate- dextran fluorescence. Proc. Natl Acad. Sci. USA 79, 2758-2762. (Pubitemid 12032311)
138. Ono, K., Kim, S.O., and Han, J. (2003). Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death. Mol. Cell. Biol. 23, 665-676. (Pubitemid 36050559)
139. Otomo, A., Pan, L., and Hadano, S. (2012). Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases. Neurol. Res. Int. 2012, 498428.
140. Palermo, C., and Joyce, J.A. (2008). Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol. Sci. 29, 22-28.
141. Palmieri, M., Impey, S., Kang, H., et al. (2011). Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20, 3852-3866.
142. Parkinson-Lawrence, E.J., Shandala, T., Prodoehl, M., et al. (2010). Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) 25, 102-115.
143. Pearce, D.A., Nosel, S.A., and Sherman, F. (1999). Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p. Mol. Genet. Metab. 66, 320-323. (Pubitemid 29390193)
144. Pereira, C., Chaves, S., Alves, S., et al. (2010). Mitochondrial degradation in acetic acid-induced yeast apoptosis: the role of Pep4 and the ADP/ATP carrier. Mol. Microbiol. 76, 1398-1410.
145. Persson, H.L., Yu, Z., Tirosh, O., et al. (2003). Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radic. Biol. Med. 34, 1295-1305. (Pubitemid 36513971)
146. Pickford, F., Masliah, E., Britschgi, M., et al. (2008). The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 2190-2199. (Pubitemid 351872337)
147. Platt, F.M., Boland, B., and van der Spoel, A.C. (2012). The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J. Cell Biol. 199, 723-734.
148. Poupetova, H., Ledvinova, J., Berna, L., et al. (2010). The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J. Inherit. Metab. Dis. 33, 387-396.
149. Puxbaum, V., Nimmerfall, E., Bauerl, C., et al. (2012).M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues. J. Hepatol. 57, 337-343.
150. Ralevic, V., and Burnstock, G. (1998 Receptors for purines and pyrimidines Pharmacol. Rev. 50, 413-492. (Pubitemid 28477681)
151. Ramessur, K.T., Greenwell, P., Nash, R., et al. (2010). Breast cancer invasion is mediated by beta-N-acetylglucosaminidase (beta-NAG) and associated with a dysregulation in the secretory pathway of cancer cells. Br. J. Biomed. Sci. 67, 189-196.
152. Ramirez, C.M., Liu, B., Aqul, A., et al. (2011). Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations. J. Lipid Res. 52, 688-698.
153. Reddy, A., Caler, E.V., and Andrews, N.W. (2001). Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes. Cell 106, 157-169. (Pubitemid 32772627)
154. Reiners, J.J., Jr, Kleinman, M., Kessel, D., et al. (2011). Nonesterified cholesterol content of lysosomes modulates susceptibility to oxidant-induced permeabilization. Free Radic. Biol. Med. 50, 281-294.
155. Roberg, K., andO? llinger, K. (1998). Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am. J. Pathol. 152, 1151-1156. (Pubitemid 28221866)
156. Roberg, K., Kagedal, K., and O?llinger, K. (2002). Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 161, 89-96. (Pubitemid 34760774)
157. Roczniak-Ferguson, A., Petit, C.S., Froehlich, F., et al. (2012). The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Science Signal. 5, ra42.
158. Rodgers, K.J., Watkins, D.J., Miller, A.L., et al. (2006). Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 26, 851-856. (Pubitemid 43732162)
159. Rodriguez, A., Webster, P., Ortego, J., et al. (1997). Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J. Cell Biol. 137, 93-104. (Pubitemid 27167298)
160. Rossi, A., Deveraux, Q., Turk, B., et al. (2004). Comprehensive search for cysteine cathepsins in the human genome. Biol. Chem. 385, 363-372. (Pubitemid 38787114)
161. Saftig, P., Schro?der, B., and Blanz, J. (2010). Lysosomal membrane proteins: life between acid and neutral conditions. Biochem. Soc. Trans. 38, 1420-1423.
162. Sardiello, M., Palmieri, M., di Ronza, A., et al. (2009). A gene network regulating lysosomal biogenesis and function. Science 325, 473-477.
163. Savic, R., and Schuchman, E.H. (2013). Use of acid sphingomyelinase for cancer therapy. Adv. Cancer Res. 117, 91-115.
164. Schestkowa, O., Geisel, D., Jacob, R., et al. (2007). The catalytically inactive precursor of cathepsin D induces apoptosis in human fibroblasts and HeLa cells. J. Cell. Biochem. 101, 1558-1566. (Pubitemid 47242783)
165. Schultz, M.L., Tecedor, L., Chang, M., et al. (2011). Clarifying lysosomal storage diseases. Trends Neurosci. 34, 401-410.
166. Schulze, H., Kolter, T., and Sandhoff, K. (2009). Principles of lysosomal membrane degradation: cellular topology and biochemistry of lysosomal lipid degradation. Biochim. Biophys. Acta 1793, 674-683.
167. Settembre, C., Di Malta, C., Polito, V.A., et al. (2011). TFEB links autophagy to lysosomal biogenesis. Science 332, 1429-1433.
168. Shen, S., Kepp, O., and Kroemer, G. (2012). The end of autophagic cell death? Autophagy 8, 1-3.
169. Shi, G.P., Sukhova, G.K., Grubb, A., et al. (1999). Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest. 104, 1191-1197. (Pubitemid 29536290)
170. Sobota, J.A., Back, N., Eipper, B.A., et al. (2009). Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal- and secretorypathway proteins. J. Cell Sci. 122, 3542-3553.
171. Soldati, T., and Neyrolles, O. (2012). Mycobacteria and the intraphagosomal environment: take it with a pinch of salt(s)! Traffic 13, 1042-1052.
172. Steele, J.W., Lachenmayer, M.L., Ju, S., et al. (2012). Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Mol. Psychiatry doi: 10.1038/mp.2012.106.
173. Steinhardt, R.A., Bi, G., and Alderton, J.M. (1994). Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science 263, 390-393. (Pubitemid 24067947)
174. Steinman, R.M., Mellman, I.S., Muller, W.A., et al. (1983). Endocytosis
175. Sukhova, G.K., Shi, G.P., Simon, D.I., et al. (1998). Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102, 576-583. (Pubitemid 28376160)
176. Taha, T.A., Kitatani, K., Bielawski, J., et al. (2005). Tumor necrosis factor induces the loss of sphingosine kinase-1 by a cathepsin B-dependent mechanism. J. Biol. Chem. 280, 17196-17202. (Pubitemid 41389186)
177. Tam, C., Idone, V., Devlin, C., et al. (2010). Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. J. Cell Biol. 189, 1027-1038.
178. Turk, B., and Turk, V. (2009). Lysosomes as 'suicide bags' in cell death: myth or reality? J. Biol. Chem. 284, 21783-21787.
179. Turk, B., Bieth, J.G., Bjork, I., et al. (1995). Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins. Biol. Chem. Hoppe Seyler 376, 225-230.
180. vanGelder, C.M.,Vollebregt,A.A., Plug, I., et al. (2012).Treatmentoptions for lysosomal storage disorders: developing insights. Expert Opin. Pharmacother. 13, 2281-2299.
181. Vancompernolle, K., VanHerreweghe, F., Pynaert, G., et al. (1998). Atractylosideinduced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 438, 150-158. (Pubitemid 28529264)
182. Vanier, M.T. (2010). Niemann-Pick disease type C. Orphanet J. Rare Dis. 5, 16.
183. Wa?ster, P.K., andO?llinger, K.M. (2009). Redox-dependent translocation of p53 to mitochondria or nucleus in human melanocytes after UVA- and UVB-induced apoptosis. J. Invest. Dermatol. 129, 1769-1781.
184. Watts, C. (2012). The endosome-lysosome pathway and information generation in the immune system. Biochim. Biophys. Acta 1824, 14-21.
185. Werneburg, N.W., Guicciardi, M.E., Bronk, S.F., et al. (2002). Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G947-G956. (Pubitemid 35033938)
186. Werneburg,N.W.,Guicciardi,M.E., Bronk, S.F.,etal. (2007).Tumornecrosis factorrelated apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J. Biol. Chem. 282, 28960-28970. (Pubitemid 47606073)
187. Whitley, C.B., Ridnour, M.D., Draper, K.A., et al. (1989). Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin. Chem. 35, 374-379. (Pubitemid 19086682)
188. Wisniewski, K.E., Golabek, A.A., and Kida, E. (1994). Increased urine concentration of subunit c of mitochondrial ATP synthase in neuronal ceroid lipofuscinoses patients. J. Inherit. Metab. Dis. 17, 205-210. (Pubitemid 24182917)
189. Woodman, P.G., and Futter, C.E. (2008). Multivesicular bodies: co-ordinated progression to maturity. Curr. Opin. Cell Biol. 20, 408-414.
190. Yamashima, T., Saido, T.C., Takita, M., et al. (1996). Transient brain ischaemia provokes Ca2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys. Eur. J. Neurosci. 8, 1932-1944.
191. Yang, D.S., Stavrides, P., Mohan, P.S., et al. (2011). Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 134, 258-277.
192. Yuan, X.M., Li, W., Brunk, U.T., et al. (2000). Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic. Biol. Med. 28, 208-218. (Pubitemid 30084013)
193. Yuan, X.M., Li, W., Dalen, H., et al. (2002). Lysosomal destabilization in p53-induced apoptosis. Proc. Natl Acad. Sci. USA 99, 6286-6291. (Pubitemid 34493304)
194. Zhang, Z., Chen, G., Zhou, W., et al. (2007). Regulated ATP release from astrocytes through lysosome exocytosis. Nat. Cell Biol. 9, 945-953. (Pubitemid 47190449)
195. Zhao, H. (2012). Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases. Traffic 13, 1307-1314.
196. Zuzarte-Luis, V., Montero, J.A.,Kawakami, Y., et al. (2007). Lysosomal cathepsins in embryonic programmed cell death. Dev. Biol. 301, 205-217. (Pubitemid 44958390)